Angiotensin II during Experimentally Simulated Central Hypovolemia

Central hypovolemia, defined as diminished blood volume in the heart and pulmonary vascular bed, is still an unresolved problem from a therapeutic point of view. The development of pharmaceutical agents targeted at specific angiotensin II receptors, such as the non-peptidergic AT(2)-receptor agonist...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Theo Walther, Olsen, Niels Vidiendal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776081/
https://www.ncbi.nlm.nih.gov/pubmed/26973842
http://dx.doi.org/10.3389/fcvm.2016.00006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776081/
https://www.ncbi.nlm.nih.gov/pubmed/26973842
http://dx.doi.org/10.3389/fcvm.2016.00006

Ejemplares similares